Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07234123 · ClinicalTrials.gov registry record · NA
Cognitive Conditioned Pain Modulation
A NA study of Healthy Participants, sponsored by University of Washington.
- Completed
- Registry status
- NA
- Development phase
- 24
- Enrollment target
- 1
- Study location
NCT07234123: Completed NA study of Healthy Participants, sponsored by University of Washington.
NCT07234123 is a NA study of Healthy Participants that has completed, run by University of Washington. The registered enrollment target is 24 participants, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07234123, a NA study of Healthy Participants, has completed, sponsored by University of Washington.
- COMPLETED
- Registry status
- NA
- Development phase
- 24 participants
- Enrollment target
- 1
- Study location
Study Summary
This "pain reduces pain" study looks at how the brain reduces pain when a person feels two painful sensations at the same time. There is considerable evidence that the brain can "turn down" pain using natural endogenous pain-control systems. The current CPM study measures whether attentional processes can also make a measurable contribution to pain inhibition alongside neurochemical mechanisms.
Primary Outcome
graphic rating scale from 0 (no pain) to 10 (excruciating pain)
Conditions Studied
Interventions
- BEHAVIORAL conditioned pain modulation
- BEHAVIORAL test stimulus
Study Locations (1)
Washington
- University of Washington Seattle - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2024-08-09 |
| Est. Completion | 2025-05-29 |
| Phase | NA |
What the finished NCT07234123 record still lists
NCT07234123 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 65-participant average among 119 other Healthy Participants trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Healthy Participants appearing as the primary indexed condition, and to 2 interventions - of which conditioned pain modulation is the first listed.
NCT07234123 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT07234123 about?
NCT07234123 is a clinical study titled "Cognitive Conditioned Pain Modulation". This "pain reduces pain" study looks at how the brain reduces pain when a person feels two painful sensations at the same time. There is considerable evidence that the brain can "turn down" pain using natural endogenous pain-control systems. The current CPM study measures whether attentional process...
What is the current status of trial NCT07234123?
This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2024-08-09. Estimated completion is 2025-05-29.
What conditions does trial NCT07234123 study?
This clinical trial studies the following conditions: Healthy Participants.
What interventions are being tested in trial NCT07234123?
The interventions under investigation include: conditioned pain modulation (BEHAVIORAL), test stimulus (BEHAVIORAL).
Who is sponsoring clinical trial NCT07234123?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07234123 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Participants
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07234123's enrollment target sits among peer trials
24 80th of 119 higher than 30 of 119 other Healthy Participants trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Participants trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact of Supplemental Fiber on Gut and Vascular Health Related in Obesity Phenotypes
RECRUITING · NA
-
Fructose Intestinal Gluconeogenesis
RECRUITING · NA
-
Royal Ancient Oats™ Study
RECRUITING · NA
-
The Increasing Mindfulness Engagement Project
RECRUITING · NA
-
Testing a Non-Invasive Spinal Stimulation Device
RECRUITING · NA
-
Glycemic/Insulinemic Effects of Fresh Mango as a Sugar Substitute in Realistic Breakfasts.
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02331979 · 24 participants · NA
Improving Bladder Function in SCI by Neuromodulation
- NCT03096197 · 24 participants · NA
Exoskeleton and Spinal Cord Stimulation for SCI
- NCT03223922 · 24 participants · NA
Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases
- NCT03326921 · 24 participants · Phase 1
HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI